ea0056oc8.2 | MicroRNAs as biomarkers in endocrine diseases | ECE2018
Assmann Tais Silveira
, Recamonde-Mendoza Mariana
, Costa Aline
, Punales Marcia
, Tschiedel Balduino
, Canani Luis Henrique
, Bauer Andrea Carla
, Crispim Daisy
Context: Diabetic kidney disease (DKD) is a common microvascular complication that affects approximately 40% of patients with diabetes mellitus (DM). This complication is the leading cause of end-stage renal disease (ESRD) in patients starting renal replacement therapy and is associated with increased cardiovascular mortality. Although a tight glycemic control is able to reduce the development and delay the progression of DKD, current therapies are still not totally effective ...